Related Experiment Video
Updated: Jan 12, 2026

05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
12.9K
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in
Gernot Ortner1, Xenia Hoderlein2, Francesco Barbato3
1Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Summary
The Pelvic Rosetta Classification (PRC) developed a landmark-based map for prostate cancer lymph node mapping, improving interdisciplinary communication. The PRC showed fair reproducibility and validity, requiring further external validation.
Area of Science:
- Urology
- Radiology
- Medical Imaging
Background:
- Accurate staging of prostate cancer relies on precise lymph node assessment.
- Interdisciplinary communication between radiologists and urologists can be challenging in pelvic lymph node mapping.
Purpose of the Study:
- To develop and validate the Pelvic Rosetta Classification (PRC), an interdisciplinary, landmark-based pelvic lymph node map for prostate cancer.
- To enhance communication and consistency in reporting pelvic lymph node status.
Main Methods:
- Development of a landmark-based lymph node map (PRC) through expert consensus meetings.
- Validation through contouring lymph node areas (LNAs) on patient imaging and assigning PET/CT-positive lesions.
- Interrater reliability assessed using Fleiss κ.
Main Results:
- Defined 8 pelvic and 4 extrapelvic LNAs using consistent anatomic landmarks.
- Achieved strong expert consensus for well-defined LNAs, moderate overall agreement (κ = 0.53) during validation.
- Identified discrepancies primarily at borders between LNAs; final map and 3D model approved by experts.
Conclusions:
- The Pelvic Rosetta Classification demonstrates fair reproducibility and validity for prostate cancer lymph node mapping.
- Further external validation is necessary to confirm its impact on interdisciplinary communication and patient treatment outcomes.

